signalasfen.blogg.se - Sources didi ximalaya linkdoc ipotimes

#SOURCES DIDI XIMALAYA LINKDOC IPOTIMES REGISTRATION#

But Hong Kong has its own obstacles, most notably tough profitability requirements that would normally disqualify a money-losing company like LinkDoc.īut the Hong Kong Stock Exchange has shown growing flexibility in the last few years to accommodate this kind of high-tech, high-growth company. IPO application means LinkDoc has begun the early confidential steps for a Hong Kong IPO that could soon lead to its first public filing. IPOs around the same time and have gone silent since then? At least one such plan appears to still be moving forward, which we’ll describe shortly.Ī potential alternative for LinkDoc and the others could be Hong Kong listings, and it’s quite possible the formal withdrawal of its U.S. listing now formally dead, the big questions are: What will LinkDoc do next, and what’s ahead for the handful of other Chinese companies that had filed for U.S.

#SOURCES DIDI XIMALAYA LINKDOC IPOTIMES REGISTRATION#

“In light of the current capital markets condition, the company is considering other alternatives and has determined not to proceed at this time with the offering and sale of the securities proposed to be covered by the registration statement,” LinkDoc said in a brief statement accompanying its withdrawal notice dated April 11.

Readers might recall this company had the misfortune of trying to list at the height of a storm centered on the Uber-like DiDi Global (NYSE:DIDI) over data security concerns from China’s cybersecurity regulator. securities regulator last week it was withdrawing its IPO application first filed last June. Medical big data firm LinkDoc Technology Ltd. has formally signaled the end of its hopes for a U.S. listings could revive their plans in the second half of this year as last year’s regulatory turmoil shows signs of receding

Three other Chinese companies with pending U.S.

IPO, nine months after its 11th hour halt to the listing

LinkDoc has formally withdrawn its plan to raise $200 million from a U.S.

listing by a Chinese firm on record, after Alibaba Group Holding Ltd.’s $25 billion blockbuster debut in 2014. this year, according to data compiled by Bloomberg. Its investors include Alibaba Health Information Technology Ltd., MBK Partners, New Enterprise Associates and Temasek Holdings Pte according to a preliminary filing.Ĭhinese companies have raised about $13 billion through first-time share sales in the U.S. LinkDoc, founded in 2014, provides cancer focused health-care services built on big data and artificial intelligence, its website shows. A representative for LinkDoc declined to comment. Reuters reported LinkDoc’s IPO halt earlier Thursday.

LinkDoc’s IPO delay also comes as regulators in Beijing are planning rule changes that would allow them to block a Chinese company from listing overseas even if the unit selling shares is incorporated outside China, closing a loophole long-used by the country’s technology giants, Bloomberg News reported this week.